Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Vaxcyte, Inc.
  6. Calendar
    PCVX   US92243G1085

VAXCYTE, INC.

(PCVX)
  Report
Delayed Nasdaq  -  05/17 04:00:00 pm EDT
25.27 USD   +2.97%
05/10TRANSCRIPT : Vaxcyte, Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-2022 02:40 PM
CI
05/09VAXCYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/09Vaxcyte Reports First Quarter 2022 Financial Results and Provides Business Update
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart VAXCYTE, INC.
Upcoming events on VAXCYTE, INC.
05/23/22 UBS Global Healthcare Conference
06/01/22 Annual General Meeting
08/17/22 Interim 2022 Earnings Release (Projected)
11/17/22 Q3 2022 Earnings Release (Projected)
03/27/23 FY 2022 Earnings Release (Projected)
Past events on VAXCYTE, INC.
05/10/22 | 05:40pm Bank of America Healthcare Conference
05/10/22 Q1 2022 Earnings Release (Projected)
04/12/22 | 12:45pm Needham Virtual Healthcare Conference
02/28/22 | 04:30pm FY 2021 Earnings Call
02/28/22 | 04:10pm FY 2021 Earnings Release
02/18/22 | 02:20pm SVB Leerink Global Healthcare Conference
12/01/21 | 04:45pm Evercore ISI HealthCONx Conference
11/22/21 | 10:00am Piper Sandler Virtual Healthcare Conference
11/18/21 | 03:00am Jefferies London Healthcare Conference
11/10/21 | 04:10pm Q3 2021 Earnings Release
Past dividends on VAXCYTE, INC.

- No events available -

Annual results
Fiscal Period : December2019202020212022
Operating income
(EBITDA)
M $		 Released
Forecast
Spread

 		-88,2
-89,8
1,8%		-102
-98,0
-3,9%		 
-123
 
Operating profit
(EBIT)
M $		 Released
Forecast
Spread

 		-89,6
-95,8
6,5%		-104
-103
-0,85%		 
-166
 
Pre-Tax Profit
(EBT)
M $		 Released
Forecast
Spread

 		-89,2
-95,5
6,6%		-100
-101
1,0%		 
-166
 
Net income
M $		 Released
Forecast
Spread		-50,3

 		-89,2
-93,4
4,5%		-100
-100
0,04%		 
-166
 
EPS
$		 Released
Forecast
Spread		-13,2

 		-3,02
-2,81
-7,5%		-1,93
-1,89
-2,3%		 
-2,83
 
Announcement Date05/22/202003/29/202102/28/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $		 Released
Forecast
Spread

 

 

 

 

 		 

 
Operating profit
(EBIT)
M $		 Released
Forecast
Spread		-23,1
-29,7
22%		-23,7
-28,3
16%		-27,0
-29,4
8,2%		-29,8
-30,3
1,4%		-39,2
-35,8
-9,6%		 
-40,6
 
Pre-Tax Profit
(EBT)
M $		 Released
Forecast
Spread		-21,2
-28,9
26%		-23,7
-26,9
12%		-26,6
-28,7
7,2%		-28,6
-29,7
3,7%		-39,0
-35,5
-9,9%		 
-40,5
 
Net income
M $		 Released
Forecast
Spread		-21,2
-28,9
26%		-23,7
-26,9
12%		-26,6
-28,7
7,2%		-28,6
-29,7
3,7%		-39,0
-35,5
-9,9%		 
-40,5
 
EPS
$		 Released
Forecast
Spread		-0,41
-0,51
20%		-0,46
-0,52
12%		-0,51
-0,55
6,7%		-0,54
-0,55
1,2%		-0,68
-0,63
-8,5%		 
-0,69
 
Announcement Date05/11/202108/11/202111/10/202102/28/202205/09/2022-
Previous year Next Year
Upcoming sector events for VAXCYTE, INC.
More events
Past sector events for VAXCYTE, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise